DCTH

Delcath Sys

• TipRanks·1d ago

  Delcath Systems announces ASCO 2026 investigator initiated trials-in-progress

• PUBT·1d ago

  Delcath Systems flags Phase 2 study sequencing HEPZATO liver perfusion with tebentafusp in metastatic uveal melanoma

• TipRanks·1d ago

  H.C. Wainwright Sticks to Its Buy Rating for Delcath Systems (DCTH)

• PUBT·05/15 20:01

  Delcath Systems grants 24,500 RSUs under 2023 inducement plan

• Reuters·05/15 20:01

  DELCATH SYSTEMS, INC. ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

• TipRanks·05/14 12:50

  Delcath Shareholders Approve Expanded Equity Plan and Governance

• PUBT·05/14 12:24

  Delcath Systems shareholders approved 1,800,000-share increase to omnibus equity plan

• PUBT·05/12 12:01

  Delcath Systems management attends H.C. Wainwright BioConnect Investor Conference

• TipRanks·05/09 01:25

  Delcath Systems Balances Growth with Rising Costs

• TipRanks·05/08 10:37

  H.C. Wainwright Reaffirms Their Buy Rating on Delcath Systems (DCTH)

• Seeking Alpha·05/08 03:32

  Delcath outlines at least $100M 2026 revenue as it targets 37 active centers by year-end

• TipRanks·05/07 14:11

  Delcath Systems presents new data on M-PHP at ESMO

• TipRanks·05/07 13:35

  Delcath Systems reports Q1 EPS (3c), consensus (9c)

• Benzinga·05/07 12:47

  Delcath Systems FY2026 Revenue expected to be more than $100.000M vs $104.070M Est

• Reuters·05/07 12:15

  Delcath Systems Q1 revenue beats on Hepzato growth